Moritani S

No ORCID on file · 4 papers in corpus · active 2021-2025

Study types

  • case-report 1
2025
Establishment of a human ovarian endometrioid carcinoma cell line by constitutive expression of cyclin-dependent kinase 4, cyclin D1 and telomerase reverse transcriptase.
Human cell ·doi:10.1007/s13577-025-01176-0

Only a few human ovarian endometrioid carcinoma cell lines are currently available, partly due to the difficulty of establishing cell lines from low-grade cancers. Here, using a cell immortalization strategy consisting of i) inactivation of…

case-report 2025
Hematometra within a cesarean scar defect in a perimenopausal woman: A case report
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/jog.16253

Cesarean scar defect (CSD) is a long-term complication of cesarean section (CS). However, its risks for perimenopausal women remain unclear. We present a rare case of CSD involving hematometra in a perimenopausal woman, which led to emergen…

2022
Retinol dehydrogenase 10 contributes to cancer stemness and intracellular carbohydrate storage in ovarian clear cell carcinomas.
Cancer biomarkers : section A of Disease markers ·doi:10.3233/cbm-210435

BackgroundOvarian clear cell carcinomas (OCCCs) have been recurrent and refractory among the present treatments, so novel therapeutics are urgently needed.ObjectiveThe present study accumulates the proof of concept to examine the feasibilit…

2021
A mixed Müllerian cystadenoma presenting as a paraurethral tumor.
Gynecologic oncology reports ·doi:10.1016/j.gore.2020.100684

•We report the first case of a paraurethral mixed Müllerian cystadenoma.•The cystic lesion was lined by a mixture of three different types of epithelium.•All epithelial cells were positive for estrogen receptor and PAX8.